Pharmaceutical Business review

Biotage signs research pact with PeptLab

Under the agreement, PeptLab will continue to provide support in technical inputs for developing Biotage related products.

Additionally, PeptLab will also offer training facilities for demonstrating Biotage’s range of peptide synthesis, purification and resin products.

Biotage president and CEO Torben Jorgensen said they are all very excited by the opportunity to work with this group and are looking forward to their collaboration across a range of activities.

Anna Maria Papini of PeptLab said the cooperation with Biotage fits perfectly with their goals both within PeptLab itself and the wider framework of the European Innovation Network.

"It is for this reason that we decided to invest in the Biotage Syro II and Syro Wave parallel peptide synthesizers for our SOSCO Laboratory in Cergy-Pontiose. These innovative tools allow us to significantly increase our peptide production as well as provide access the more challenging peptides via the microwave heating capability of the Syro Wave," Papini said.